Cargando…
ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147906/ https://www.ncbi.nlm.nih.gov/pubmed/34034690 http://dx.doi.org/10.1186/s12889-021-11012-3 |
_version_ | 1783697731883106304 |
---|---|
author | Gilchrist, Gail Potts, Laura Radcliffe, Polly Halliwell, Gemma Dheensa, Sandi Henderson, Juliet Johnson, Amy Love, Beverly Gilchrist, Elizabeth Feder, Gene Parrott, Steve Li, Jinshuo McMurran, Mary Kirkpatrick, Sara Stephens-Lewis, Danielle Easton, Caroline Berbary, Cassandra Landau, Sabine |
author_facet | Gilchrist, Gail Potts, Laura Radcliffe, Polly Halliwell, Gemma Dheensa, Sandi Henderson, Juliet Johnson, Amy Love, Beverly Gilchrist, Elizabeth Feder, Gene Parrott, Steve Li, Jinshuo McMurran, Mary Kirkpatrick, Sara Stephens-Lewis, Danielle Easton, Caroline Berbary, Cassandra Landau, Sabine |
author_sort | Gilchrist, Gail |
collection | PubMed |
description | BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention to reduce IPA by men in substance use treatment was explored. A multicentre, parallel group individually randomised controlled feasibility trial and formative evaluation was conducted. Over three temporal cycles, 104 men who had perpetrated IPA towards a female (ex) partner in the past year were randomly allocated to receive the ADVANCE intervention + substance use treatment as usual (TAU) (n = 54) or TAU only (n = 50) and assessed 16-weeks post-randomisation. Participants’ (ex) partners were offered support and 27 provided outcome data. Thirty-one staff and 12 men who attended the intervention participated in focus groups or interviews that were analysed using the framework approach. Pre-specified criteria assessed the feasibility of progression to a definitive trial: 1) ≥ 60% of eligible male participants recruited; 2) intervention acceptable to staff and male participants; 3) ≥ 70% of participants followed-up and 4) levels of substance use and 5) IPA perpetrated by men in the intervention arm did not increase from average baseline level at 16-weeks post-randomisation. RESULTS: 70.7% (104/147) of eligible men were recruited. The formative evaluation confirmed the intervention’s acceptability. Therapeutic alliance and session satisfaction were rated highly. The overall median rate of intervention session attendance (of 14 compulsory sessions) was 28.6% (range 14.3–64.3% by the third cycle). 49.0% (51/104) of men and 63.0% (17/27) of their (ex) partners were followed-up 16-weeks post-randomisation. This increased to 100% of men and women by cycle three. At follow-up, neither substance use nor IPA perpetration had worsened for men in the intervention arm. CONCLUSIONS: It was feasible to deliver the ADVANCE intervention in substance use treatment services, although it proved difficult to collect data from female (ex)partners. While some progression criteria were met, others were not, although improvements were demonstrated by the third cycle. Lessons learned will be implemented into the study design for a definitive trial of the ADVANCE intervention. TRIAL REGISTRATION: ISRCTN79435190 prospectively registered 22nd May 2018. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11012-3. |
format | Online Article Text |
id | pubmed-8147906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81479062021-05-26 ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial Gilchrist, Gail Potts, Laura Radcliffe, Polly Halliwell, Gemma Dheensa, Sandi Henderson, Juliet Johnson, Amy Love, Beverly Gilchrist, Elizabeth Feder, Gene Parrott, Steve Li, Jinshuo McMurran, Mary Kirkpatrick, Sara Stephens-Lewis, Danielle Easton, Caroline Berbary, Cassandra Landau, Sabine BMC Public Health Research BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention to reduce IPA by men in substance use treatment was explored. A multicentre, parallel group individually randomised controlled feasibility trial and formative evaluation was conducted. Over three temporal cycles, 104 men who had perpetrated IPA towards a female (ex) partner in the past year were randomly allocated to receive the ADVANCE intervention + substance use treatment as usual (TAU) (n = 54) or TAU only (n = 50) and assessed 16-weeks post-randomisation. Participants’ (ex) partners were offered support and 27 provided outcome data. Thirty-one staff and 12 men who attended the intervention participated in focus groups or interviews that were analysed using the framework approach. Pre-specified criteria assessed the feasibility of progression to a definitive trial: 1) ≥ 60% of eligible male participants recruited; 2) intervention acceptable to staff and male participants; 3) ≥ 70% of participants followed-up and 4) levels of substance use and 5) IPA perpetrated by men in the intervention arm did not increase from average baseline level at 16-weeks post-randomisation. RESULTS: 70.7% (104/147) of eligible men were recruited. The formative evaluation confirmed the intervention’s acceptability. Therapeutic alliance and session satisfaction were rated highly. The overall median rate of intervention session attendance (of 14 compulsory sessions) was 28.6% (range 14.3–64.3% by the third cycle). 49.0% (51/104) of men and 63.0% (17/27) of their (ex) partners were followed-up 16-weeks post-randomisation. This increased to 100% of men and women by cycle three. At follow-up, neither substance use nor IPA perpetration had worsened for men in the intervention arm. CONCLUSIONS: It was feasible to deliver the ADVANCE intervention in substance use treatment services, although it proved difficult to collect data from female (ex)partners. While some progression criteria were met, others were not, although improvements were demonstrated by the third cycle. Lessons learned will be implemented into the study design for a definitive trial of the ADVANCE intervention. TRIAL REGISTRATION: ISRCTN79435190 prospectively registered 22nd May 2018. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11012-3. BioMed Central 2021-05-25 /pmc/articles/PMC8147906/ /pubmed/34034690 http://dx.doi.org/10.1186/s12889-021-11012-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Gilchrist, Gail Potts, Laura Radcliffe, Polly Halliwell, Gemma Dheensa, Sandi Henderson, Juliet Johnson, Amy Love, Beverly Gilchrist, Elizabeth Feder, Gene Parrott, Steve Li, Jinshuo McMurran, Mary Kirkpatrick, Sara Stephens-Lewis, Danielle Easton, Caroline Berbary, Cassandra Landau, Sabine ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title | ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title_full | ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title_fullStr | ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title_full_unstemmed | ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title_short | ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
title_sort | advance integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147906/ https://www.ncbi.nlm.nih.gov/pubmed/34034690 http://dx.doi.org/10.1186/s12889-021-11012-3 |
work_keys_str_mv | AT gilchristgail advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT pottslaura advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT radcliffepolly advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT halliwellgemma advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT dheensasandi advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT hendersonjuliet advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT johnsonamy advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT lovebeverly advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT gilchristelizabeth advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT federgene advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT parrottsteve advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT lijinshuo advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT mcmurranmary advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT kirkpatricksara advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT stephenslewisdanielle advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT eastoncaroline advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT berbarycassandra advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial AT landausabine advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial |